Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
- PMID: 19648920
- PMCID: PMC3313685
- DOI: 10.1038/ng.421
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer
Erratum in
- Nat Genet. 2009 Oct;41(10):1156. Guarrera, Simonetta [added]; Polidoro, Silvia [added]
Abstract
We conducted a genome-wide association study on 969 bladder cancer cases and 957 controls from Texas. For fast-track validation, we evaluated 60 SNPs in three additional US populations and validated the top SNP in nine European populations. A missense variant (rs2294008) in the PSCA gene showed consistent association with bladder cancer in US and European populations. Combining all subjects (6,667 cases, 39,590 controls), the overall P-value was 2.14 x 10(-10) and the allelic odds ratio was 1.15 (95% confidence interval 1.10-1.20). rs2294008 alters the start codon and is predicted to cause truncation of nine amino acids from the N-terminal signal sequence of the primary PSCA translation product. In vitro reporter gene assay showed that the variant allele significantly reduced promoter activity. Resequencing of the PSCA genomic region showed that rs2294008 is the only common missense SNP in PSCA. Our data identify rs2294008 as a new bladder cancer susceptibility locus.
Figures
References
-
- Jemal A, et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008;58:71–96. - PubMed
-
- Lichtenstein P, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 2000;343:78–85. - PubMed
-
- Kiemeney LA. Familial bladder cancer. In: Lerner SP, Schoenberg M, Sternberg C, editors. Textbook of Bladder Cancer. London: T&F-Informa; 2006. pp. 19–25.
-
- Kantor AF, Hartge P, Hoover RN, Fraumeni JF., Jr Familial and environmental interactions in bladder cancer risk. Int. J. Cancer. 1985;35:703–706. - PubMed
-
- Kiemeney LA, Schoenberg M. Familial transitional cell carcinoma. J. Urol. 1996;156:867–872. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA131335/CA/NCI NIH HHS/United States
- P42 ES007373/ES/NIEHS NIH HHS/United States
- R01 CA 74880/CA/NCI NIH HHS/United States
- P50 CA098258/CA/NCI NIH HHS/United States
- U01 CA 127615/CA/NCI NIH HHS/United States
- A4994/CRUK_/Cancer Research UK/United Kingdom
- P50 CA 91846/CA/NCI NIH HHS/United States
- P42 ES07373/ES/NIEHS NIH HHS/United States
- R01 CA057494/CA/NCI NIH HHS/United States
- R01 CA 133996/CA/NCI NIH HHS/United States
- P50 CA091846/CA/NCI NIH HHS/United States
- R01 CA074880/CA/NCI NIH HHS/United States
- T32 CA096520/CA/NCI NIH HHS/United States
- R01 CA133996/CA/NCI NIH HHS/United States
- U01 CA127615/CA/NCI NIH HHS/United States
- R01 CA 131335/CA/NCI NIH HHS/United States
- R01 CA 57494/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
